Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP
Clinical trial NCT06054269 · COMPLETED
Trial details
- NCT number
- NCT06054269
- Sponsor
- Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-04
- Primary completion
- 2023-07-25
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.